1. Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis 
C. Calabrese, A. Tosco, P. Abete, V. Carnovale, C. Basile, A. Magliocca, S. Quattrucci, S. De Sanctis, F. Alatri, G. Mazzarella, L. De Pietro, C. Turino, E. Melillo, P. Buonpensiero, A. Di Pasqua, V. Raia 
Journal of Cystic Fibrosis 
Volume 14, Issue 2, Pages (March 2015)
DOI: /j.jcf
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

2. Fig. 1
Study timeline.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

3. Fig. 2 Flow diagram of study population.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

4. Fig. 3
Changes from baseline of FEV1 at each study visit measured in children as liter with standard error (A) and percentage predicted with standard error (B); in adults as liter with standard error (C) and percentage predicted with standard error (D); in patients with FEV1% <81% as liter with standard error (E) and percentage predicted with standard error (F); in patients with FEV1% >81% as liter with standard error (G) and percentage predicted with standard error (H). Dark gray: glutathione; light gray: placebo.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions